News
📈 Stocks
BioCryst Targets Rare Disease Expansion After Reaching Profitability
(5 days ago)
BioCryst aims to diversify its rare disease portfolio using Orladeyo's cash flow, though significant debt obligations and clinical execution risks remain key…